Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.
Takeda Pharmaceutical Co. executives have agreed to pay more than $2.3 billion to resolve lawsuits accusing the company of hiding its Actos diabetes medicine’s cancer risks, three people familiar with the accord said.
The state has enjoyed success funding and building life sciences companies, and the new Indiana Biosciences Research Institute should give it a further boost, according to panelists Friday at IBJ's Life Sciences Power Breakfast.
Indiana University Health announced Friday that the $1 billion project consolidating its downtown hospitals will take five to seven years to complete, during which time University Hospital will remain open to patients just as it is now.
To satisfy patients with high-deductible health plans, Northwest Radiology has introduced flat-rate pricing for its imaging scans. It’s a centuries-old concept among postal services, but for health care, it’s revolutionary.
Four residents of the town of Princeton sued to revoke the university's tax exemption, in part because it shares royalties with faculty, mostly from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.
Things got quiet after a wave of hospital systems' acquiring physician practices swept through central Indiana from 2008 to 2011. But a new wave could start now that Congress passed the "doc fix" last week.